MedTrace Logo

Herbal Therapy for Subcutaneous Injection Site Reactions in Multiple Sclerosis

NCT00972062 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2012-03-07

No results posted yet for this study

Summary

The purpose of this study is to determine if an herbal over-the-counter cream can decrease skin site reactions in multiple sclerosis patients who currently take either Betaseron, Copaxone or Rebif as their subcutaneous medication for managing their multiple sclerosis. Injection site reactions have been indicated as one of the major reasons for discontinuing treatment with the subcutaneous medications (Betaseron, Copaxone, and Rebif) for multiple sclerosis.

Conditions

Interventions

OTHER

Bach's Rescue Remedy Cream

0.5 ml of cream applied to skin site reactions as needed

OTHER

Placebo Cream

Placebo cream 0.5 ml two times a day as needed

Sponsors & Collaborators

  • Teva Branded Pharmaceutical Products R&D, Inc.

    collaborator INDUSTRY

  • University of North Carolina, Charlotte

    lead OTHER

Principal Investigators

  • Linda A Moore, EdD, APRN · University of North Carolina at Charlotte

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2009-12-31
Completion
2010-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00972062 on ClinicalTrials.gov